Published in Curr Genomics on April 01, 2017
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09
Cancer genome landscapes. Science (2013) 25.33
Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Wnt/β-catenin signaling and disease. Cell (2012) 16.05
Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer (2002) 15.72
Tumour stem cells and drug resistance. Nat Rev Cancer (2005) 15.21
Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod (2012) 13.27
NF-kappaB at the crossroads of life and death. Nat Immunol (2002) 12.98
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Cancer stem cells: an old idea--a paradigm shift. Cancer Res (2006) 9.76
The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet (2010) 8.81
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res (2006) 7.91
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
Stem cell concepts renew cancer research. Blood (2008) 6.74
The human ATP-binding cassette (ABC) transporter superfamily. Genome Res (2001) 5.47
Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol (2003) 5.40
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol (2006) 5.17
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science (2007) 5.08
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature (2009) 4.99
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature (1990) 4.69
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol (2010) 4.22
Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell (2006) 4.09
The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood (2002) 4.02
The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol (2013) 3.84
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A (1997) 3.84
The influence of natural products upon drug discovery. Nat Prod Rep (2000) 3.59
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47
ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer (2010) 3.44
The role of natural product chemistry in drug discovery. J Nat Prod (2004) 3.39
Dishevelled: The hub of Wnt signaling. Cell Signal (2009) 3.31
Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov (2012) 3.25
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A (2007) 3.23
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood (2005) 3.22
The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol (2012) 3.16
Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev (2009) 3.15
A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem Sci (2000) 3.09
NF-kappaB as a therapeutic target in cancer. Trends Mol Med (2002) 3.08
Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol (1997) 3.01
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell (2008) 3.01
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol (2011) 2.74
Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem (2001) 2.71
Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (2007) 2.65
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med (2009) 2.60
Notch and cancer: a double-edged sword. Cell Mol Life Sci (2007) 2.59
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (2010) 2.55
ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia (2009) 2.43
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer (2011) 2.41
Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol (2004) 2.35
Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol (2013) 2.35
Can we safely target the WNT pathway? Nat Rev Drug Discov (2014) 2.31
Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett (2011) 2.24
Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci U S A (2006) 2.23
Hedgehog regulates smoothened activity by inducing a conformational switch. Nature (2007) 2.23
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol (2010) 2.20
Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin Pharmacol Ther (2011) 2.04
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol (2015) 2.02
Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr Top Dev Biol (2010) 2.00
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res (2007) 1.98
Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol (2007) 1.91
Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett (2005) 1.90
The Hedgehog signal transduction network. Sci Signal (2012) 1.80
Wnt signaling in stem and cancer stem cells. Semin Cell Dev Biol (2010) 1.79
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat (2009) 1.77
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene (2007) 1.76
Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J (2010) 1.73
Therapeutic modulation of Notch signalling--are we there yet? Nat Rev Drug Discov (2014) 1.73
Multidrug resistance transporters and modulation. Curr Opin Oncol (2000) 1.71
Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One (2011) 1.67
Drugging Wnt signalling in cancer. EMBO J (2012) 1.63
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene (2003) 1.57
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res (2011) 1.57
Notch inhibitors for cancer treatment. Pharmacol Ther (2013) 1.55
Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) (2012) 1.54
The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat (2014) 1.54
Wnt/β-catenin signalling in prostate cancer. Nat Rev Urol (2012) 1.52
NF-κB is 25. Nat Immunol (2011) 1.50
Twenty-five years of research on medicinal plants in Latin America: a personal view. J Ethnopharmacol (2005) 1.49
Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. BMC Cancer (2010) 1.48
A historical overview of natural products in drug discovery. Metabolites (2012) 1.47
Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol (2008) 1.46
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res (2013) 1.43
Camptothecin: current perspectives. Bioorg Med Chem (2004) 1.42
Cancer stem cells: A contentious hypothesis now moving forward. Cancer Lett (2013) 1.40
Beta-catenin signaling in prostate cancer: an early perspective. Endocr Relat Cancer (2003) 1.38
Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets (2011) 1.35
The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem (2000) 1.34
ABC A-subfamily transporters: structure, function and disease. Biochim Biophys Acta (2006) 1.33
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett (2011) 1.33
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle (2011) 1.32
NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat Commun (2013) 1.31
Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett (2007) 1.30
Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One (2011) 1.30
Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol (2004) 1.29
The role of hedgehog signalling in tumorigenesis. Cancer Lett (2001) 1.28